Sei Investments Co. Increases Stake in Cardinal Health, Inc. $CAH

Sei Investments Co. increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 8.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 746,712 shares of the company’s stock after buying an additional 60,340 shares during the period. Sei Investments Co.’s holdings in Cardinal Health were worth $157,787,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. University of Texas Texas AM Investment Management Co. bought a new position in shares of Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC purchased a new stake in Cardinal Health in the fourth quarter worth $28,000. Finally, Indiana Trust & Investment Management Co bought a new position in Cardinal Health in the first quarter worth $29,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 2.3%

Cardinal Health stock opened at $225.54 on Friday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The company has a market capitalization of $52.82 billion, a price-to-earnings ratio of 34.49, a price-to-earnings-growth ratio of 1.08 and a beta of 0.49. The business’s fifty day simple moving average is $219.32 and its two-hundred day simple moving average is $214.34.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.50%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Mizuho upped their target price on shares of Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Thursday. Wells Fargo & Company decreased their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. UBS Group lifted their price target on shares of Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a research report on Monday. Finally, Evercore cut their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $250.40.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.